Dynamk Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.
BiotechDeep TechHardwareMedical DevicesAtlanta, US
Alla Zamarayeva, PhD(CEO & Co-founder)inTodd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)Alla Zamarayeva(CEO & Co-founder)inTodd Sulchek(CSO & Co-founder)inAlex Alexeev(Co-founder)in
Co-investorsCota CapitalGreatPoint VenturesM VenturesEmbark VenturesKhosla Ventures
Lucid Scientific develops Resipher, a technology for live, continuous, and noninvasive monitoring of cellular oxygen consumption rate to study cell metabolism.
BiotechDeep TechHardwareAtlanta, US
Samuel Walker Inman(Executive Officer, Director)Ian W. Hunter(Executive Officer, Director)
BoardDr. Gustavo Mahler(Director)in
Co-investorsGRA VentureIAG Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.